These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 605981)

  • 1. [State of the blood coagulation and anticoagulation system in women taking oral contraceptives].
    Terskaia LV; Guseva AM; Golubeva LA; Fedotova MA
    Akush Ginekol (Mosk); 1977 Dec; (12):41-3. PubMed ID: 605981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
    Hashmi JA; Kazi AB; Kazi A; Ali N
    J Pak Med Assoc (1951); 1972 Aug; 22(8):218-25. PubMed ID: 12305803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid function tests under the effect of steroidal contraceptives compared to normal pregnancy.
    Nasr EM; El-mekkawi T; Abbas A; El-sheikha Z; Abdel Aziz A
    Popul Sci; 1982; (3):157-68. PubMed ID: 12266214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation studies in women using combination type of oral contraceptives.
    Sharma S; Sharma M; Soni IJ; Gupta A; Jain R
    J Obstet Gynaecol India; 1983 Aug; 33(4):519-24. PubMed ID: 12339832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal contraception--side effects and surgical aspects (author's transl)].
    Göretzlehner G; Carol W; Köhler G
    Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some observations on the changes in capillary resistance in oral contraceptive users.
    Zaki K; Younis MN; Razek SA; Mekkawi TE; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):145-51. PubMed ID: 12256025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of blood coagulation parameters.
    Newman RL; Sirridge M; Brinkman M; Shannon R
    Am J Obstet Gynecol; 1976 May; 125(1):108-14. PubMed ID: 775991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
    Balogh A; Ditrói F; Lampé LG
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation studies in women on combination type of oral contraceptives.
    Gupta K; Nain S; Manikeri S; Sheth UK; Vaidya P; Mandlekar A; Krishna UR
    J Obstet Gynaecol India; 1979 Jun; 29(3):647-9. PubMed ID: 12335923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of anovulatory steroids on serum levels of zinc and copper].
    Dorea JG; Ferraz E; Queiroz EF
    Arch Latinoam Nutr; 1982 Mar; 32(1):101-10. PubMed ID: 7181622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on inhibitors of blood coagulation and fibrinolysis during use of oral contraceptives].
    Miyaji K
    Nihon Funin Gakkai Zasshi; 1982 Apr; 27(2):242-50. PubMed ID: 12158577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J; Kluft C
    Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The renin-angiotensin system and total body sodium and potassium in hypertensive women taking oestrogen-progestagen oral contraceptives.
    McAreavey D; Cumming AM; Boddy K; Brown JJ; Fraser R; Leckie BJ; Lever AF; Morton JJ; Robertson JI; Williams ED
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):111-8. PubMed ID: 6851195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history].
    Manuilova IA; Dubnitskaia LV; Korsakov SG
    Akush Ginekol (Mosk); 1989 Jul; (7):48-51. PubMed ID: 2478038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of switching with oral contraceptives.
    Wassef SA; Sami G; Hamid EA
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):77-93. PubMed ID: 12254511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.